Filter
939
Filtered Results: 939
Text search:
pharmaceutical
industry
Featured
Recommendations
64
New Publications
227
Language
Document type
No document type
443
Studies & Reports
224
Guidelines
142
Strategic & Response Plan
53
Manuals
44
Fact sheets
11
Situation Updates
8
Training Material
4
Brochures
3
Resource Platforms
3
Infographics
2
Online Courses
2
Countries / Regions
India
53
Global
48
Kenya
44
South Africa
24
Ethiopia
23
Nepal
18
Nigeria
18
Ghana
16
Sierra Leone
16
Uganda
16
Bangladesh
14
Philippines
12
Zambia
12
Indonesia
11
Ukraine
10
Africa
10
Tanzania
10
Western and Central Europe
10
Syria
9
Zimbabwe
9
Latin America and the Carribbean
9
Namibia
9
Myanmar / Burma
9
Rwanda
8
Botswana
8
Lesotho
7
Malawi
7
West and Central Africa
7
South–East Asia Region
6
Mozambique
5
Cambodia
5
Eastern Europe
5
Asia
4
Venezuela
4
East and Southern Africa
4
Liberia
4
Eswatini/ Swaziland
4
Thailand
3
Papua New Guinea
3
Pakistan
3
China
2
Laos
2
Senegal
2
Burkina Faso
2
Afghanistan
2
USA
2
Haiti
2
Jordan
2
Congo, Democratic Republic of
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
South Sudan
2
Tajikistan
1
Colombia
1
Timor Leste/ East Timor
1
Benin
1
Chile
1
Cameroon
1
Iran
1
Albania
1
Kyrgyzstan
1
Guinea
1
Lithuania
1
Germany
1
Saudi Arabia
1
Western Pacific Region
1
Paraguay
1
North America
1
Turkmenistan
1
Japan
1
Denmark
1
Belgium
1
Maldives
1
United Kingdom
1
Argentina
1
Lebanon
1
Vietnam
1
Brazil
1
Moldova
1
Sri Lanka
1
Russia
1
Egypt
1
Sudan
1
Central African Republic
1
Mali
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
360
Clinical Guidelines
49
Public Health
47
Key Resources
40
Pharmacy & Technologies
18
Women & Child Health
12
Capacity Building
6
Annual Report MEDBOX
2
Toolboxes
AMR
132
Pharmacy
86
COVID-19
70
Planetary Health
43
Mental Health
42
HIV
35
Rapid Response
31
NCDs
28
Global Health Education
28
TB
23
Health Financing Toolbox
21
NTDs
20
Caregiver
18
Conflict
18
Ebola & Marburg
15
Specific Hazards
13
Refugee
4
Disability
3
Zika
3
Polio
3
Natural Hazards
2
Social Ethics
2
Cholera
1
This is the first national Policy to combat AMR in Cambodia. It was developed based on conclusions and recommendations of a country situaytion analysis.
The Council was established in late 2020 by Dr Tedros Adhanom
Ghebreyesus (Director-General, WHO) to provide new economic thinking – reassessing how health and wellbeing are valued, produced and distributed across the economy. An all-female group of 10 distinguished economists and area experts, t...
Community pharmacists are the health professionals most accessible to the public and are a cornerstone of primary health care. The role of community pharmacists is expanding globally. This report provides an overview of existing components and provisions of the legal and regulatory framework for com...
Accessed on 04.04.2023
The Drugs for Neglected Diseases initiative (DNDi) is an international
non-profit organization that discovers, develops, and delivers safe,
effective, and affordable treatments for the most neglected patients
Climate change (CC) impacts on health outcomes, both direct and indirect, are sufficient to jeopardize achieving the World Bank Group’s visions and agendas in poverty reduction, population resilience, and health, nutrition and population (HNP). In the last 5 years, the number of voices calling for...
Healthcare Waste Management Toolkit for Global Fund Practitioners and Policy Makers. Part B
Antimicrobial resistance (AMR) is a global threat that requires urgent collaborative action within and among countries. AMR makes standard treatments ineffective and facilitates the spread of antimicrobial resistant infections rendering communities vulnerable. The Ministry of Health (MOH) and Minist...
Antimicrobial resistance (AMR) both in human and veterinary medicine has reached alarming levels in
most parts of the world and has now been recognized as a significant emerging threat to global public
health and food security. In June 2015, the Food and Agriculture Organization of the United Nati...
The Coronavirus Disease 2019 (COVID-19) has had a continuous and robust impact on world health. The resulting COVID-19 pandemic has had a devastating physical, mental and fiscal impact on the millions of people living with noncommunicable diseases (NCDs), as they have a higher risk of severe illness...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
2nd edition .
This Framework applies to the sharing of H5N1 and other influenza viruses with human pandemic potential and the sharing of benefits. This Framework does not apply to seasonal influenza viruses or other non-influenza pathogens or biological substances that may be contained in clinical ...
Report of a regional workshop, New Delhi, India, 29–30 September 2014
To reduce the burden of cardiovascular disease and its subsequent problems, the WHO Regional Office for South-East Asia organized a regional workshop on sodium intake and iodized salt for Member States in the South-East Asi...
To reduce the burden of cardiovascular disease and its subsequent problems, the WHO Regional Office for South-East Asia organized a regional workshop on sodium intake and iodized salt for Member States in the South-East Asi...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o...
